Concepts (132)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Chemokine CXCL10 | 3 | 2019 | 565 | 1.22 | Why? |
| Tuberculosis | 9 | 2021 | 2895 | 0.91 | Why? |
| Latent Tuberculosis | 5 | 2019 | 324 | 0.86 | Why? |
| Interferon-gamma Release Tests | 2 | 2019 | 253 | 0.77 | Why? |
| Mycobacterium tuberculosis | 6 | 2019 | 1164 | 0.72 | Why? |
| Enzyme-Linked Immunospot Assay | 1 | 2018 | 325 | 0.67 | Why? |
| Interferon-gamma | 3 | 2021 | 2711 | 0.56 | Why? |
| Antitubercular Agents | 2 | 2018 | 775 | 0.23 | Why? |
| Pneumonia | 2 | 2018 | 5652 | 0.23 | Why? |
| Biomarkers | 4 | 2021 | 23361 | 0.22 | Why? |
| Transglutaminases | 1 | 2021 | 77 | 0.21 | Why? |
| Coinfection | 1 | 2021 | 6820 | 0.21 | Why? |
| GTP-Binding Proteins | 1 | 2021 | 132 | 0.21 | Why? |
| Biological Products | 3 | 2020 | 2331 | 0.21 | Why? |
| Echinococcosis, Hepatic | 1 | 2019 | 18 | 0.19 | Why? |
| Complement C1q | 1 | 2018 | 31 | 0.19 | Why? |
| Antigens, Viral | 3 | 2021 | 6298 | 0.19 | Why? |
| Mycobacterium smegmatis | 1 | 2018 | 27 | 0.19 | Why? |
| Echinococcosis | 1 | 2019 | 40 | 0.19 | Why? |
| Hyperalgesia | 1 | 2019 | 61 | 0.19 | Why? |
| Blood Cells | 1 | 2019 | 104 | 0.18 | Why? |
| Interferon Regulatory Factor-3 | 1 | 2021 | 379 | 0.18 | Why? |
| Phosphates | 1 | 2018 | 135 | 0.18 | Why? |
| Bacterial Load | 1 | 2018 | 179 | 0.18 | Why? |
| Antigens, Bacterial | 1 | 2021 | 330 | 0.17 | Why? |
| Tuberculosis, Pleural | 1 | 2017 | 22 | 0.17 | Why? |
| Sarcoidosis, Pulmonary | 1 | 2018 | 91 | 0.17 | Why? |
| Th2 Cells | 1 | 2020 | 680 | 0.16 | Why? |
| Purines | 1 | 2021 | 816 | 0.14 | Why? |
| Coronaviridae | 1 | 2021 | 923 | 0.14 | Why? |
| Azetidines | 1 | 2021 | 722 | 0.14 | Why? |
| Blood Proteins | 1 | 2018 | 551 | 0.14 | Why? |
| Spondylitis, Ankylosing | 1 | 2017 | 231 | 0.14 | Why? |
| Th1 Cells | 1 | 2020 | 1228 | 0.14 | Why? |
| Viral Tropism | 1 | 2021 | 1329 | 0.12 | Why? |
| Sulfonamides | 1 | 2021 | 1294 | 0.12 | Why? |
| Cytokines | 4 | 2021 | 15010 | 0.11 | Why? |
| Pleural Effusion | 1 | 2017 | 680 | 0.11 | Why? |
| Arthritis, Psoriatic | 1 | 2017 | 625 | 0.11 | Why? |
| Membrane Proteins | 1 | 2021 | 1733 | 0.10 | Why? |
| Pyrazoles | 1 | 2021 | 1791 | 0.10 | Why? |
| Interferon-alpha | 1 | 2018 | 1442 | 0.10 | Why? |
| Bacterial Proteins | 1 | 2018 | 1318 | 0.10 | Why? |
| Case-Control Studies | 2 | 2018 | 17671 | 0.10 | Why? |
| Dendritic Cells | 1 | 2018 | 1330 | 0.09 | Why? |
| Thorax | 1 | 2019 | 1873 | 0.09 | Why? |
| Tuberculosis, Pulmonary | 1 | 2018 | 1171 | 0.09 | Why? |
| Immunity, Cellular | 1 | 2021 | 3614 | 0.09 | Why? |
| Spike Glycoprotein, Coronavirus | 4 | 2021 | 37182 | 0.08 | Why? |
| Antirheumatic Agents | 2 | 2019 | 3023 | 0.08 | Why? |
| Signal Transduction | 1 | 2021 | 7207 | 0.07 | Why? |
| Models, Biological | 1 | 2021 | 4907 | 0.07 | Why? |
| Humans | 23 | 2021 | 930598 | 0.07 | Why? |
| T-Lymphocytes | 1 | 2021 | 6670 | 0.07 | Why? |
| Arthritis, Rheumatoid | 1 | 2017 | 2043 | 0.06 | Why? |
| Virus Diseases | 1 | 2020 | 3779 | 0.06 | Why? |
| Predictive Value of Tests | 1 | 2018 | 9537 | 0.06 | Why? |
| Immunity, Innate | 1 | 2021 | 6570 | 0.06 | Why? |
| Virus Internalization | 1 | 2021 | 7921 | 0.06 | Why? |
| Anti-Inflammatory Agents | 1 | 2020 | 6153 | 0.06 | Why? |
| Reproducibility of Results | 1 | 2018 | 11304 | 0.06 | Why? |
| Adult | 7 | 2021 | 244371 | 0.05 | Why? |
| Host-Pathogen Interactions | 2 | 2018 | 11041 | 0.05 | Why? |
| Middle Aged | 6 | 2021 | 270681 | 0.05 | Why? |
| Follow-Up Studies | 1 | 2018 | 17020 | 0.05 | Why? |
| Microorganisms, Genetically-Modified | 1 | 2018 | 19 | 0.05 | Why? |
| Respiratory Tract Infections | 1 | 2020 | 6817 | 0.05 | Why? |
| Tumor Cells, Cultured | 1 | 2019 | 254 | 0.05 | Why? |
| Bacterial Adhesion | 1 | 2018 | 69 | 0.05 | Why? |
| United Nations | 1 | 2021 | 367 | 0.04 | Why? |
| Gene Expression Regulation, Bacterial | 1 | 2018 | 143 | 0.04 | Why? |
| Nontuberculous Mycobacteria | 1 | 2019 | 114 | 0.04 | Why? |
| Male | 7 | 2020 | 367725 | 0.04 | Why? |
| Pleurisy | 1 | 2017 | 18 | 0.04 | Why? |
| Antiviral Agents | 2 | 2021 | 41703 | 0.04 | Why? |
| Tumor Necrosis Factor-alpha | 2 | 2018 | 2483 | 0.04 | Why? |
| Coronaviridae Infections | 1 | 2021 | 442 | 0.04 | Why? |
| Female | 6 | 2020 | 380317 | 0.04 | Why? |
| Immunoglobulin G | 1 | 2020 | 21571 | 0.04 | Why? |
| Biological Assay | 1 | 2019 | 367 | 0.04 | Why? |
| Mycobacterium Infections, Nontuberculous | 1 | 2018 | 167 | 0.04 | Why? |
| Mice, Knockout | 1 | 2021 | 1815 | 0.04 | Why? |
| Primates | 1 | 2018 | 584 | 0.04 | Why? |
| Hepatectomy | 1 | 2019 | 276 | 0.04 | Why? |
| Interferon-beta | 1 | 2021 | 979 | 0.04 | Why? |
| Spleen | 1 | 2018 | 877 | 0.03 | Why? |
| Aged | 3 | 2020 | 215776 | 0.03 | Why? |
| Cell Membrane | 1 | 2018 | 743 | 0.03 | Why? |
| Rheumatic Diseases | 2 | 2019 | 2675 | 0.03 | Why? |
| Antigens, CD | 1 | 2018 | 984 | 0.03 | Why? |
| A549 Cells | 1 | 2018 | 2066 | 0.03 | Why? |
| Down-Regulation | 1 | 2018 | 1416 | 0.03 | Why? |
| BCG Vaccine | 1 | 2020 | 1137 | 0.03 | Why? |
| Cells, Cultured | 1 | 2021 | 5835 | 0.02 | Why? |
| Dexamethasone | 1 | 2020 | 2055 | 0.02 | Why? |
| Animals | 4 | 2021 | 78931 | 0.02 | Why? |
| Inflammation Mediators | 1 | 2020 | 2654 | 0.02 | Why? |
| Mass Screening | 2 | 2019 | 8005 | 0.02 | Why? |
| Acute Disease | 1 | 2021 | 6029 | 0.02 | Why? |
| Mice, Inbred C57BL | 1 | 2018 | 5542 | 0.02 | Why? |
| Drug Therapy, Combination | 1 | 2020 | 7268 | 0.02 | Why? |
| Macrophages | 1 | 2018 | 2784 | 0.02 | Why? |
| Influenza A Virus, H1N1 Subtype | 1 | 2020 | 2984 | 0.02 | Why? |
| Protein Domains | 1 | 2018 | 6563 | 0.02 | Why? |
| Liver | 1 | 2019 | 4007 | 0.02 | Why? |
| CD8-Positive T-Lymphocytes | 1 | 2021 | 5837 | 0.02 | Why? |
| Diagnosis, Differential | 1 | 2018 | 7220 | 0.02 | Why? |
| Adenosine Monophosphate | 1 | 2020 | 5652 | 0.02 | Why? |
| Alanine | 1 | 2020 | 5687 | 0.02 | Why? |
| Mice | 1 | 2021 | 21357 | 0.01 | Why? |
| Epidemics | 1 | 2020 | 6407 | 0.01 | Why? |
| Risk Factors | 2 | 2019 | 71621 | 0.01 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2020 | 9335 | 0.01 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 1 | 2020 | 8843 | 0.01 | Why? |
| Antibodies, Viral | 2 | 2021 | 51949 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2019 | 22971 | 0.01 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2020 | 12361 | 0.01 | Why? |
| Influenza, Human | 1 | 2020 | 10779 | 0.01 | Why? |
| HIV Infections | 1 | 2020 | 11620 | 0.01 | Why? |
| Practice Guidelines as Topic | 1 | 2019 | 15421 | 0.01 | Why? |
| Public Health | 1 | 2020 | 16359 | 0.01 | Why? |
| Intensive Care Units | 1 | 2020 | 29594 | 0.01 | Why? |
| RNA, Viral | 1 | 2021 | 32276 | 0.01 | Why? |
| Lung | 1 | 2020 | 31049 | 0.01 | Why? |
| Retrospective Studies | 1 | 2020 | 105322 | 0.01 | Why? |
| Pandemics | 3 | 2021 | 389249 | 0.01 | Why? |
| Aged, 80 and over | 1 | 2018 | 88759 | 0.01 | Why? |
| Adolescent | 1 | 2018 | 86841 | 0.01 | Why? |
| Young Adult | 1 | 2018 | 93724 | 0.01 | Why? |
| Betacoronavirus | 1 | 2020 | 204454 | 0.00 | Why? |
| Pneumonia, Viral | 1 | 2020 | 243684 | 0.00 | Why? |
| Coronavirus Infections | 1 | 2020 | 253789 | 0.00 | Why? |
Petrone's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(132)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(139)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_